Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.677

Abstract | Full Article | PDF

675-the-analytical-validation-of-the-oncotype-dx-recurrence-score-assay

Research: The analytical validation of the Oncotype DX Recurrence Score assay

Frederick L Baehner

26 Sep 2016

https://doi.org/10.3332/ecancer.2016.675

Abstract | Full Article | PDF

674-is-blue-dye-still-required-during-sentinel-lymph-node-biopsy-for-breast-cancer

Clinical Study: Is blue dye still required during sentinel lymph node biopsy for breast cancer?

Mirjam CL Peek, Tibor Kovacs, Rose Baker, Hisham Hamed, Ash Kothari, Michael Douek

19 Sep 2016

https://doi.org/10.3332/ecancer.2016.674

Abstract | Full Article | PDF

670-maps-and-atlases-of-cancer-mortality-a-review-of-a-useful-tool-to-trigger-new-questions

Review: Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions

Alberto d'Onofrio, Chiara Mazzetta, Chris Robertson, Michel Smans, Peter Boyle, Mathieu Boniol

1 Sep 2016

https://doi.org/10.3332/ecancer.2016.670

Abstract | Full Article | PDF

669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Richard Schilsky, Will Davies

24 Aug 2016

https://doi.org/10.3332/ecancer.2016.669

Abstract | Full Article | PDF

659-a-web-based-interactive-tool-to-improve-breast-cancer-patient-centredness

Research: A web-based interactive tool to improve breast cancer patient centredness

Alessandra Gorini, Ketti Mazzocco, Haridimos Kondylakis, Gordon McVie, Gabriella Pravettoni

26 Jul 2016

https://doi.org/10.3332/ecancer.2016.659

Abstract | Full Article | PDF

658-highlights-from-the-first-international-ecancer-conference-on-oncology-and-radiotherapy-6-7-may-2016-santiago-chile

Conference Report: Highlights from the first International ecancer Conference on Oncology and Radiotherapy, 6–7 May 2016, Santiago, Chile

Leonardo Carmona Reimann, Beatriz Amendola

22 Jul 2016

https://doi.org/10.3332/ecancer.2016.658

Abstract | Full Article | PDF | Spanish

647-a-prognostic-index-for-locoregional-recurrence-after-neoadjuvant-chemotherapy

Clinical Study: A prognostic index for locoregional recurrence after neoadjuvant chemotherapy

C Herrero-Vicent, A Guerrero-Zotano, J Gavilá-Gregori, A Hernández-Blanquisett, S Sandiego-Contreras, JM Samper-Hiraldo, V Guillem-Porta, A Ruiz-Simón

16 Jun 2016

https://doi.org/10.3332/ecancer.2016.647

Abstract | Full Article | PDF

644-highlights-from-the-tenth-european-breast-cancer-conference-ebcc10-amsterdam-9-11-march-2016

Conference Report: Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9–11 March 2016

Joana Ribeiro, Maria João Cardoso

3 Jun 2016

https://doi.org/10.3332/ecancer.2016.644

Abstract | Full Article | PDF

632-characterisation-of-the-triple-negative-breast-cancer-phenotype-associated-with-the-development-of-central-nervous-system-metastases

Review: Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

Katerin Rojas Laimito, Angelo Gámez-Pozo, Juan Sepúlveda, Luis Manso, Rocío López-Vacas, Tomás Pascual, Juan A Fresno Vara, Eva Ciruelos

11 Apr 2016

https://doi.org/10.3332/ecancer.2016.632

Abstract | Full Article | PDF | Spanish

More from ecancer